RANDOMIZED TRIAL OF A SINGLE, DOUBLE AND TRIPLE DOSE OF 10 MG/KG OF A HUMAN FORMULATION OF TRICLABENDAZOLE IN PATIENTS WITH FASCIOLIASIS | Publicación